January 2012 : Publication. The journal Applied Environmental Microbiology published a collaborative study between EVOLUGATE, LLC and scientists at the FOUNDATION FOR APPLIED MOLECULAR EVOLUTION and at the UNIVERSITY OF FLORIDA that discloses the first use of our technology to experimentally evolve industrially important bacterium E. coli, which is among the most widely used microorganisms for industrial and biomedical applications. In this case, the goal was to develop a starter strain that can be further evolved to develop high temperature bioprocesses. See publications.
Mars 2011 : Research Grant. Evolugate was awarded a phase 1 SBIR grant from the Army Research Laboratory to increase the maximal growth temperature of a strain of heterotrophic algae. The objective is to improve the conversion of algal oil to bio jet-fuel. See More...
June 2010 : Event. Evolugate Launches Bioremediation Project to Mitigate the Gulf Oil Spill. Evolugate announces the initiation of this project with scientists taking actual samples of oil from contaminated sites in the Gulf and beginning to culture microbial communities uniquely adapted for biodegrading these samples. More information... Illustrated Press Release June 3rd
February 2010 : Nominations. Two experienced CEOs join the Advisory Board of Evolugate, LLC. The company is proud to announce the appointment of Russell J. Howard and Terrance J. Bruggeman to its Advisory Board. More information...
August 26, 2009 : Publication. The open access journal BMC Biotechnology published a collaborative study between EVOLUGATE, LLC and scientists at the UNIVERSITY OF FLORIDA that discloses the first use of our technology to experimentally evolve industrially important filamentous fungi, which are among the most widely used microorganisms for industrial applications. In this case, the goal was to evolve improved "green" bio-pesticides. More information...
February 2009 : Nomination. Evolugate is happy to welcome Ewa Hughes, M.S. as a research scientist in the Evolugate team. Ewa is a molecular biologist who worked as an embryologist in the Animal Sciences Dept. at UF. She brings with her a wealth of experience in culturing human and animal cells as well as traditional molecular and cellular biology. She is driven to take on new challenges and is excited about the research opportunities presented by Evolugate.
December 2008 : Nomination. Evolugate is happy to announce that Dr. Thomas Lyons, formerly of the University of Florida Dept. of Chemistry, has decided to join the Evolugate team as Principal Research Scientist. Dr. Lyons ran a successful research program that focused on studying a novel family of receptors. His major contribution was the discovery that these receptors work by producing lipid second messengers. He was drawn to Evolugate by the power of the Evolugator technology and the chance to apply it to serious problems like biofuel and bioinsecticide development. Dr. Lyons brings with him expertise in biochemistry, molecular and cellular biology, microbiology and genetics.
August 2007 : Publication, V. de Crécy-Lagard et Al. "Development of a wall growth free continuous culture device for experimental evolution of bacterial populations". Applied Microbiology & Biotechnology. See publications
February 2007 : Collaboration agreement. Pursuant to its agreement with the University of Florida, Evolugate is collaborating with Dr. Nemat Keyhani, Department of Microbiology and Cell Science, for the purpose of improving bioinsecticide capabilities of fungi. http://microcell.ufl.edu/personnel/faculty/keyhani1.shtml
November 2006 : Collaboration agreement. Evolugate began an academic collaboration with Dr. Jim Spain, School of Civil and Environmental Engineering, Georgia Institute of Technology, for the purpose of improving the yield of degradation of certain wild-type micro-organisms. http://www.ce.gatech.edu/people/faculty/671/overview
April 2005 : Collaboration agreement. Evolugate entered into an academic collaboration agreement with University of Florida to help academic laboratories select more efficient micro-organisms using our continuous culture technology.